Britt Meelby Jensen
From 2019 Britt Meelby Jensen served as CEO of Swedish Atos Medical until she led the sale. From 2015 to 2019 Britt Meelby Jensen was CEO of Zealand Pharma.
Category Britt Meelby Jensen Wikimedia Commons
From 2019 Britt Meelby Jensen served as CEO of Swedish Atos Medical until she led the sale of the company to Coloplast in early 2022.
. Britt Meelby Jensen has served as board member of Ambu since 2019 a position she will step down from when she takes over the position as CEO on 20 May 2022 and replaces Juan Jose Gonzalez who will leave Ambu after three years and support the. Britt Meelby Jensen has served as board member of The Board of Directors of Ambu AS has appointed Britt Meelby Jensen as new Chief Executive Officer CEO. Britt Meelby Jensen vil genskabe tilliden til Ambu.
Britt Meelby Jensen har senest været administrerende direktør for Swedish Atos Medical der senere blev solgt til til Coloplast. From 2019 Britt Meelby Jensen served as CEO of Swedish Atos Medical until she led the sale of the company to Coloplast in early 2022. From 2015 to 2019 Britt Meelby Jensen was CEO of Zealand Pharma.
Competencies and special tasks on the Board. 21 hours agoBritt Meelby Jensen was CEO of Malmö Sweden-based medical device developer Altos Medical from 2019 until March 1 stepping down after the laryngectomy care companys acquisition by Humlebaek. His place at the helm will be taken over by Britt Meelby Jensen who has been a board member of Ambu since 2019 a position she leaves as part of the executive reshuffle.
1 day agoEffective tomorrow May 20 Juan Jose Gonzalez will no longer be the chief executive of Danish medtech firm Ambu the firm has announced in a press release. I am very pleased to welcome Britt to the Novo Holdings Board of Directors said Lars Rebien Sørensen Chairman of the Boards of Novo Holdings and the Novo Nordisk Foundation. After three years at the front of Swedish medtech company Atos Medical Britt Meelby Jensen has set the date for when she will leave the company a press release announces.
På valg i 2024. Direktør i det børsnoterede medicinalselskab Zealand Pharma samt haft en række chefstillinger i Novo Nordisk. 1 day agoA seasoned life science CEO Britt Meelby Jensen born in 1973 has more than 20 years of experience from the life science industry.
The Board of Directors of Ambu AS has appointed Britt Meelby Jensen as new Chief Executive Officer. Britt Meelby Jensen Accelerating Danish biotech business Malin Otmani June 13 2018 2244 Views She has been called the Danish biotech queen and she is not afraid of responsibility in her role as CEO. View Britt Meelby Jensens professional profile on Relationship Science the database of decision makers.
Making a difference has always been my motivational force and I also considered going into politics. From 2019 Britt Meelby Jensen served as CEO of Swedish Atos. Jensen previously was Chief Executive Officer at Zealand Pharma A Chief Executive Officer at Atos Medical AB Vice President General Manager at Dako Denmark ApS and Chief Executive Officer for Dako ApS.
1 day agoBritt Meelby Jensen born in 1973 has more than 20 years of experience from the life science industry. International Marketing Management Copenhagen Business School 2000 MBA Economics Solvay Business. 4 hours agoUd over Atos Medical har Britt Meelby Jensen blandt andet siddet i Ambus betyrelse siden 2019.
The Board of Directors of Ambu AS has appointed Britt Meelby Jensen as new Chief Executive Officer CEO. Fra 2015-2019 var Britt Meelby Jensen administrerende direktør for det børsnoterede biotekselskab Zealand Pharma og hun har tidligere også stået i spidsen for Dako og har haft ledende stillinger i Novo Nordisk. Developing medicine to make a better life for.
On the contrary Britt Meelby Jensen enjoys leading setting ambitious goals and accelerating company growth. Britt Meelby Jensen is Vice President at Agilent Technologies Inc. Genvalgt senest i 2021.
From 2019 to early 2022 Britt Meelby Jensen served as CEO of Atos Medical AB. Det vil hun rette op på Den erfarne topchef Britt Meelby Jensen skal nu vende udviklingen i det pressede medicoselskab Ambu. Hun har derudover også tidligere været adm.
Britt Meelby Jensen is a multifaceted woman and as CEO in Zealand Pharma one of few women holding a top position in the 30 publicly listed Danish life science companies MedWatch has reviewed. Britt has over twenty years of experience from the life science industry pharma diagnostics biotech and medtech. In connection with selling the company to Coloplast Britt decided to step down as CEO to continue as an adviser as of March 2022.
Britt Meelby Jensen will be continuing in her role in the Novo Advisory Group where she has served since 2020. Press Releases One News Page. A seasoned life science CEO Britt Meelby Jensen born in 1973 has more than 20 years of experience from the life science industry.
Kompetencer og særlige opgaver i bestyrelsen. Britt Meelby Jensen has served as board member of Ambu since 2019 a position she will step down from when she takes over the position as CEO on 20 May 2022 and replaces Juan Jose Gonzalez who will leave Ambu after three years and support the new CEO in the transition as needed. On March 1 2022 the former Zealand Pharma CEO steps back from the position in Atos Medical which Coloplast acquired for EUR 22bn in November.
Summary Britt Meelby Jensen is on the board of Novo Holdings An and 6 other companies. Britt Meelby Jensen born in 1973 has more than 20 years of experience from the life science industry. Britt is a highly competent and experienced life.
Since Juan Jose Gonzalez joined as CEO in 2019 Ambu has made. Ambus nye topchef Britt Meelby Jensen erkender at syv nedjusteringer på tre år har tæret på tilliden til selskabet. Britt Meelby Jensen København Hovedstaden Danmark500 forbindelser Tilmeld dig for at oprette forbindelse Artikler af Britt Meelby Interview with Kristian Villumsen CEO of.
International Marketing Management Copenhagen Business School 2000.
Interview Of The Week Csilla Kohalmi Monfils Director Of Innovation Ecosystems Engie Fab The Innovator
Adriana Carpenter Joins Emburse As Chief Financial Officer Citybiz
Barbara Harcavi Parenting Coach And Couples Counselor
Pa Consulting Welcomes Tracey Countryman As Head Of Markets 23 March 2022 Pa Consulting
Seneste Nyheder Om Britt Meelby Jensen Finans Dk
Britt Meelby Jensen Steps Down As Ceo Of Atos Medical
Marit Muller To Become Avacon S New Chief Human Resources Officer Energate Messenger Com
6haiqn Ios6v8m
Troester Named New Director Of Center For Environmental Health And Susceptibility Unc Gillings School Of Global Public Health
Britt Meelby Jensen Crunchbase Person Profile
How Ikea Maintains Workplace Culture For 170 000 Distributed Employees Quartz At Work
Britt Meelby Jensen Leaves Zealand Pharma Nordic Life Science The Leading Nordic Life Science News Service
2
Accelerated Doctor Of Pharmacy Pharmd Mcphs Worcester And Manchester Youtube
Legal Consultant Limelight Patty Morrissy Lawdragon
Cheryl Matejka Senior Vice President And Chief Financial Officer Mercy
Britt Meelby Jensen Is The New Ceo Of Atos Medical Nordic Life Science The Leading Nordic Life Science News Service
Novo Holdings Britt Meelby Jensen Joins The Advisory Group Of Novo Holdings
Britt Meelby Jensen Hempel Foundation